Document Detail

The association between preeclampsia and placental disruption induced by chorionic villous sampling.
MedLine Citation:
PMID:  20509159     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: The objectives of this study were (1) to evaluate if the elevation of maternal serum alpha-feto protein (MSAFP) and pregnancy-associated placental protein-A (PAPP-A) in the maternal blood after chorionic villous sampling (CVS) is associated with a higher preeclampsia (PE) rate and (2) to verify the clinical utility of the analytes elevation for predicting PE.
METHODS: A prospective study on 106 subjects who underwent CVS was performed. At the time of CVS, two blood samples were obtained for MSAFP and PAPP-A dosage, the first just before the procedure, and the second one 30 min after the procedure. Cases with abnormal karyotype, major anomalies or preterm delivery were subsequently excluded. The ratio between the two samples was calculated as Sigma (MSAFP or PAPP-A post-CVS/MSAFP or PAPP-A pre-CVS) and it was related to subsequent occurrence of PE.
RESULTS: The rate of PE was 5.7% (6/106). Both MSAFP and PAPP-A levels were higher after than before CVS (median ratio = 8.33 and 1.08, respectively). Cases developing PE had significantly higher MSAFP ratio (11.6 vs 7.4, p-value = 0.04) and PAPP-A ratio (1.13 vs 1.08, p-value = 0.009) than those who did not develop PE. Receiver operating characteristic curve analysis showed that PAPP-A ratio was a better predictor of subsequent PE than MSAFP ratio: at a fixed false positive rate of 10%, the detection rates for MSAFP and PAPP-A ratios were 33 and 50%, respectively.
CONCLUSION: The elevation of MSAFP and PAPP-A observed with CVS is associated with increased risk of subsequent PE. The ability of such increases to predict PE appears to be modest.
Antonio Farina; Junichi Hasegawa; Simonetta Raffaelli; Chiara Ceccarini; Giuseppina Rapacchia; M Carla Pittalis; Lorena Brondelli; Francesca Righetti; Nicola Rizzo
Related Documents :
21585639 - Placental expression of a novel primate-specific splice variant of sflt-1 is upregulate...
3124999 - Risks of chorion villus sampling.
15294369 - Parental decisions following the prenatal diagnosis of sex chromosome abnormalities.
23072309 - Unilateral striae distensae affecting the right axilla in a 16-year-old boy: brief report.
1471659 - The smaller than expected first-trimester fetus is at increased risk for chromosome ano...
23577419 - Lessons learned from introducing an in-vitro maturation programme into clinical practice.
10065169 - New peptides, hormones and parturition.
3331879 - Pregnancy outcome following ultrasound diagnosis of fetal urinary tract anomalies and/o...
3960429 - Fetal respiratory movements: only part of the biophysical profile.
Publication Detail:
Type:  Evaluation Studies; Journal Article    
Journal Detail:
Title:  Prenatal diagnosis     Volume:  30     ISSN:  1097-0223     ISO Abbreviation:  Prenat. Diagn.     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-05-28     Completed Date:  2010-09-17     Revised Date:  2010-12-13    
Medline Journal Info:
Nlm Unique ID:  8106540     Medline TA:  Prenat Diagn     Country:  England    
Other Details:
Languages:  eng     Pagination:  571-4     Citation Subset:  IM    
Department of Obstetrics and Gynecology, St Orsola Malpighi Hospital, University of Bologna, 40138 Bologna, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Abruptio Placentae / blood,  epidemiology*,  etiology*
Biological Markers / analysis,  blood
Chorionic Villi Sampling / adverse effects*,  statistics & numerical data*
Cohort Studies
Pre-Eclampsia / blood,  diagnosis,  epidemiology*
Pregnancy-Associated Plasma Protein-A / analysis
ROC Curve
alpha-Fetoproteins / analysis
Reg. No./Substance:
0/AFP protein, human; 0/Biological Markers; 0/alpha-Fetoproteins; EC 3.4.24.-/Pregnancy-Associated Plasma Protein-A
Comment In:
Prenat Diagn. 2010 Dec;30(12-13):1230-2   [PMID:  21113917 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  First-trimester placental growth factor as a marker for hypertensive disorders and SGA.
Next Document:  Invasive prenatal testing decisions in pregnancy after infertility.